Traditional Chinese medicine leader Yuyantang finds tonic in aging population
The company has filed for a Hong Kong IPO, thriving on China’s growing silver economy and a steady stream of government policies supporting traditional Chinese medicine Key Takeaways: Yuyantang has…
RELATED ARTICLES
-
Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare
2667.HK - Chinese medicine firm seeks elusive elixir of IPO success
- Tong Ren Tang Healthcare makes trading debut, backed by 39% annual patient growth
-
JBM Healthcare gets bitter pill from investors on anemic performance
2161.HK
- Gushengtang steps up TCM buying spree, doubling down in Beijing
- Investors flee Yan Palace as aging brand struggles to find new audience
-
Confined to Hong Kong, Lung Fung lacks tonic for growth-hungry investors
2290.HK
